MUSK and myasthenia gravis: Very recently Li and co-workers showed that NT-1654 attenuated clinical severity, effectively promoted the clustering of AChRs at NMJs, and alleviated the impairment of NMJ transmission, as well as the reduction of muscle-specific kinase (MuSK) in a rat model of experimental autoimmune myasthenia gravis (53).